Drug safety watch: tracking side effects in Tough-to-Treat prostate cancer
NCT ID NCT06733337
Summary
This study is monitoring the safety and side effects of the drug Talzenna in men with a specific, advanced form of prostate cancer. It involves men whose cancer has spread and continues to grow despite low hormone levels, and who have a specific genetic change (BRCA mutation). The main goal is to track any health problems that occur while patients take the drug over a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pfizer Japan
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.